- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01831245
Right-sided Colon Tumor, Laparoscopic Versus Open Surgery, in an ERAS Protocol
Right-sided Colon Tumor, Laparoscopic and Open Surgery, in an ERAS Protocol
Register study. Patients who had been operated for right-sided colon tumor or benign adenoids between year 2011 to 2012. The study compare open surgery with laparoscopic surgery in an ERAS (Enhanced Recovery After Surgery) protocol.
Hypothesis:
Operation of right-sided colon tumor and large benign adenoids, a better selection of patients for open or laparoscopic surgery can improve short term results.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Stockholm, Sweden, 116 91
- Ersta Hospital
-
Stockholm, Sweden, 182 88
- Danderyds Hospital
-
Örebro, Sweden, 701 85
- Orebro University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- right-sided colon tumor or large benign adenoids
Exclusion Criteria:
- none
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pathological Anatomic diagnosis (PAD) on a tumor biopsy
Time Frame: day of surgery
|
After PAD result, malign or benign tumor, type of malign tumor,tumor growth, stage, lymphatic recharge. Right selection of patients to laparoscopic versus open surgery in relation to PAD result? |
day of surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Length of hospital stay, days
Time Frame: 30 days after surgery
|
Compare laparoscopic versus open surgery
|
30 days after surgery
|
C - reactive protein
Time Frame: 1-7 days after surgery
|
Inflammation answer laparoscopic versus open surgery
|
1-7 days after surgery
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Immobilizing patient after surgery
Time Frame: 4 -10 hours after surgery
|
After laparoscopic versus open surgery
|
4 -10 hours after surgery
|
Leakage of anastomosis
Time Frame: 0 - 30 days after surgery
|
Compare laparoscopic versus open surgery
|
0 - 30 days after surgery
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2012/2105-31/2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colon Tumor
-
University Hospitals Cleveland Medical CenterApollo Endosurgery, Inc.CompletedColon Malignant Tumor | Colon Benign TumorUnited States
-
Assistance Publique - Hôpitaux de ParisVR 4 GOODRecruitingPain, Postoperative | Colon Tumor, Malignant | Rectum TumorFrance
-
Neovii BiotechCompletedMalignant Ascites | EpCam Positive Tumor (e.g.Ovarian, Gastric, Colon, Breast)
-
University Hospital, GrenobleRecruitingPrimary Tumor | Colon TumorFrance
-
Irish Clinical Outcomes in Research and EducationThe Cleveland ClinicUnknown
-
Asha NayakMerck Sharp & Dohme LLC; Oncovir, Inc.Completed
-
Intuitive SurgicalActive, not recruitingColorectal Cancer | Benign or Malignant Rectal or Colon TumorsUnited States, Korea, Republic of
-
Bordeaux Colorectal Institute AcademyRecruitingColorectal Surgery | Benign or Malignant Rectal or Colon TumorsFrance
-
Intuitive SurgicalCompletedBenign Colorectal Neoplasm | Benign Colon Tumor | Malignant Colorectal TumorUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Stage IIIC Rectal Cancer | Stage IIIC Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer | Stage IVB Colon Cancer | Stage IVB Rectal CancerUnited States